错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth

  • Ziwen Li,
  • Yameng Hu,
  • Haiqing Zheng,
  • Man Li,
  • Yuanji Liu,
  • Rongni Feng,
  • Xincheng Li,
  • Shuxia Zhang,
  • Miaoling Tang,
  • Meisongzhu Yang,
  • Ruyuan Yu,
  • Yingru Xu,
  • Xinyi Liao,
  • Suwen Chen,
  • Wanying Qian,
  • Qiliang Zhang,
  • Daolin Tang,
  • Bo Li,
  • Libing Song,
  • Jun Li

摘要

The mechanisms underlying the dynamic remodelling of cellular membrane phospholipids to prevent phospholipid peroxidation-induced membrane damage and evade ferroptosis, a non-apoptotic form of cell death driven by iron-dependent lipid peroxidation, remain poorly understood. Here we show that lysophosphatidylcholine acyltransferase 1 (LPCAT1) plays a critical role in ferroptosis resistance by increasing membrane phospholipid saturation via the Lands cycle, thereby reducing membrane levels of polyunsaturated fatty acids, protecting cells from phospholipid peroxidation-induced membrane damage and inhibiting ferroptosis. Furthermore, the enhanced in vivo tumour-forming capability of tumour cells is closely associated with the upregulation of LPCAT1 and emergence of a ferroptosis-resistant state. Combining LPCAT1 inhibition with a ferroptosis inducer synergistically triggers ferroptosis and suppresses tumour growth. Therefore, our results unveil a plausible role for LPCAT1 in evading ferroptosis and suggest it as a promising target for clinical intervention in human cancer.